发明名称 Novel immunomodulating compounds
摘要 A compound of formula I wherein: X represents a bond or a group selected from substituted or unsubstituted alkyl, NH-C(O)-alkyl, NH-C(O)-CH2-O-CH2 or C(O)-NH-(amino acid residue); Y represents NR4, O or S; R1 represents H, halo, CF3, lower alkyl or lower alkoxy; R2 and R4 represents independently H or lower alkyl; and R3 represents H, halo, lower alkyl or lower alkoxy; Wherein halo represents F, Cl or Br; lower alkyl represents saturated or unsaturated, straight, branched or cyclic alkyl froups having 1-6 carbon atoms; and lower alkoxy represents saturated or unsaturated, straight, branched or cyclic alkoxy groups having 1-6 carbon atoms, with the proviso that R2 is not H, when X is a bond, Y is NH and R3 is H. Also disclosed is a pharmaceutical composition comprising said compound, for the treatment of medical conditions from the group of: rheumatoid arthritis, multiple sclerosis, diabetes, asthma, transplantation, systemic lupus, eruthematosis and psoriasis.
申请公布号 NZ530316(A) 申请公布日期 2004.08.27
申请号 NZ20020530316 申请日期 2002.07.02
申请人 ACTIVE BIOTECH AB 发明人 BJORK, PER AXEL;FEX, TOMAS;PETTERSSON, LARS OLOF GORAN;SORENSEN, POUL;DA GRACA THRIGE, DORTH
分类号 A61K31/4162;A61K31/4745;A61P3/10;A61P11/06;A61P17/06;A61P19/02;A61P25/00;A61P29/00;A61P37/02;A61P37/06;A61P43/00;C07D471/04;C07D491/04;C07D491/052;C07D495/04;(IPC1-7):C07D471/04;A61K31/474;A61K31/416 主分类号 A61K31/4162
代理机构 代理人
主权项
地址